Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
Rhea-AI Summary
Terns Pharmaceuticals (Nasdaq: TERN) announced that senior management will present at the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:30 p.m. GMT.
A live webcast will be available on the company's investor relations site at http://ir.ternspharma.com, and a replay will be archived on the site for at least 30 days after the event.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, TERN gained 13.30%, reflecting a significant positive market reaction. Argus tracked a peak move of +8.0% during that session. Our momentum scanner triggered 51 alerts that day, indicating high trading interest and price volatility. This price movement added approximately $246M to the company's valuation, bringing the market cap to $2.10B at that time.
Data tracked by StockTitan Argus on the day of publication.
FOSTER CITY, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that members of senior management will be presenting at the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:30 p.m. GMT.
A live webcast of the presentation will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcast will be archived on Terns’ website for at least 30 days following the event.
About Terns Pharmaceuticals
Terns Pharmaceuticals is a clinical-stage oncology company reimagining known biology to deliver high impact medicines. Our lead program TERN-701 is a highly selective, allosteric BCR-ABL inhibitor with a potentially best-in-disease profile that could meaningfully improve upon the efficacy, safety and convenience of existing treatments for CML. For more information, please visit: www.ternspharma.com.
Contacts for Terns
Investors
Justin Ng
investors@ternspharma.com
Media
Jenna Urban
CG Life
media@ternspharma.com
FAQ
When will Terns Pharmaceuticals (TERN) present at the Jefferies Global Healthcare Conference in London?
How can investors watch the TERN presentation at the Jefferies conference?
Will there be a replay of Terns Pharmaceuticals' (TERN) Jefferies presentation and for how long?
Which Terns management will present at the Jefferies Global Healthcare Conference (TERN)?
Where can I find the webcast link for the Terns (TERN) presentation after the event?
